Reliability and standardization are the new metrics of success as the industry attempts to ensure that biological data is reproducible across different batches and global locations. This shift follows a decade of intense focus on the computational "dry lab" side of drug discovery, where artificial
Autonomous laboratories are reducing the cost of innovation by allowing researchers to explore broad scientific domains with a minimal number of physical experiments. This shift represents a fundamental transformation in how LG AI Research approaches machine intelligence, moving away from broad,
Automated monitoring systems can track organoid morphology in real-time, providing critical data points that are nearly impossible to capture through manual inspection. This technological leap, driven by the collaboration between Molecular Devices and STEMCELL Technologies, addresses the historical
Rising demand for genomic research across Europe is pushing the regional automated nucleic acid extraction market toward a projected valuation of three billion dollars by 2035. This significant shift marks a definitive departure from traditional manual sample preparation methods that have long
With over 1,000 patents filed and nearly 400 papers accepted at global conferences, the institute has already addressed more than 100 distinct industrial challenges. As LG AI Research pushes the boundaries of innovation, the current landscape of industrial research is witnessing a profound
CordenPharma is proactively responding to the evolving healthcare landscape by enhancing its capabilities in assembling auto-injectors and other complex drug delivery formats for chronic disease management. As the global pharmaceutical market shifts towards self-administered therapies, the demand
